- Trials with a EudraCT protocol (319)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
319 result(s) found for: Retina.
Displaying page 1 of 16.
EudraCT Number: 2006-001678-25 | Sponsor Protocol Number: 138/06 | Start Date*: 2006-02-16 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Macular structure and function after intravitreal injection of bevacizumab for vascular retinopathy a interventional study. | |||||||||||||
Medical condition: vascular retinopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010336-18 | Sponsor Protocol Number: HCU01-09 | Start Date*: 2010-02-15 | |||||||||||
Sponsor Name:Maria Antonia Saornil Alvarez | |||||||||||||
Full Title: Influencia del acetónido de triamcinolona y del ranibizumab en la retinopatía post irradiación en el melanoma de úvea | |||||||||||||
Medical condition: Retinopatía post-radiación en el melanoma de úvea | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003374-24 | Sponsor Protocol Number: OP-2005-01 | Start Date*: 2005-09-12 | |||||||||||
Sponsor Name:OPOCRIN S.P.A. | |||||||||||||
Full Title: A phase 2, controlled, multi-center pilot study to evaluate the efficacy and safety of Deligoparin in subjects with retinal vein occlusion of recent onset. | |||||||||||||
Medical condition: Treatment of retinal vein occlusion. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002193-37 | Sponsor Protocol Number: CHAD1031 | Start Date*: 2014-09-05 | ||||||||||||||||
Sponsor Name:Moorfields Eye Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: A phase 3 multi-centre double-masked randomised controlled trial of adjunctive intraocular and periocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretina... | ||||||||||||||||||
Medical condition: retinal detachment and the development of scarring (proliferative vitreoretinopathy) in patients with open globe trauma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001571-37 | Sponsor Protocol Number: AAV2/2-hRPE65p-hRPE65 | Start Date*: 2006-12-14 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: AN OPEN-LABEL DOSE ESCALATION STUDY OF AN ADENO-ASSOCIATED VIRUS VECTOR (AAV2/2-hRPE65p-hRPE65) FOR GENE THERAPY OF SEVERE EARLY-ONSET RETINAL DEGENERATION | |||||||||||||
Medical condition: The condition to be investigated is severe early-onset inherited retinal degeneration due to defects in the gene encoding RPE65 | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000379-41 | Sponsor Protocol Number: RLBUHT3407 | Start Date*: 2007-05-22 | |||||||||||
Sponsor Name:Royal Liverpool & Broadgreen University hospital | |||||||||||||
Full Title: Liverpool Avastin Dose Response and Retreatment Study | |||||||||||||
Medical condition: Exudative senile macular degeneration of the retina | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004656-38 | Sponsor Protocol Number: CRF002EVA | Start Date*: 2015-03-11 | ||||||||||||||||
Sponsor Name:Prof. Dr. Karl-Heinz Emmerich | ||||||||||||||||||
Full Title: Assessment of the suitability of serum VEGF level as diagnostic factor in macula edema caused by retinal or central retinal vein occlusion under therapy with Lucentis® (ranibizumab) | ||||||||||||||||||
Medical condition: Central retinal vein occlusion Retinal vein occlusion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000800-13 | Sponsor Protocol Number: V1 | Start Date*: 2013-01-24 | |||||||||||||||||||||
Sponsor Name:Universitätsklinik für Augenheilkunde und Optometrie | |||||||||||||||||||||||
Full Title: Influence of sustained-release dexamethasone on intraocular cytokines and growth factors and retinal blood vessels in retinal vein occlusion | |||||||||||||||||||||||
Medical condition: Retinal vein occlusion | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-013062-11 | Sponsor Protocol Number: AR-OCUL-1 | Start Date*: 2007-03-29 | |||||||||||
Sponsor Name:AZIENDA USL 8 AREZZO | |||||||||||||
Full Title: BEVACIZUMAB COMBINED WITH PDT, VERSUS RANIBIZUMAB AND PEGAPTANIB BOTH COMBINED WITH PDT FOR NEOVACULAR AGE RELATED MACULAR DEGENERATION CLINICAL TRIAL | |||||||||||||
Medical condition: Neovascular Age Related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006290-90 | Sponsor Protocol Number: AU-06102G | Start Date*: 2008-10-10 | |||||||||||
Sponsor Name:Society (Institute) for clinical research | |||||||||||||
Full Title: Subretinal Macugen for neovascular age-related macular degeneration (SUMANA) | |||||||||||||
Medical condition: Neovascular (exudative) age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001281-33 | Sponsor Protocol Number: RGHT000449 | Start Date*: 2007-07-09 | |||||||||||
Sponsor Name:Belfast Health and Social Care Trust [...] | |||||||||||||
Full Title: A randomised control trial of alternative treatments to Inhibit VEGf in Age-related choroidal Neovascularisation(IVAN) | |||||||||||||
Medical condition: Choroidal neovascularisation in age related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016158-42 | Sponsor Protocol Number: IT-04-1-8-09 | Start Date*: 2009-12-23 | |||||||||||
Sponsor Name:U.L.S.S. 16 | |||||||||||||
Full Title: Efficacy of intravitreal bevacizumab for exudative age-related macular degeneration. | |||||||||||||
Medical condition: Exudative age-related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004367-57 | Sponsor Protocol Number: | Start Date*: 2008-05-14 | |||||||||||
Sponsor Name:Department of Ophthalmology, Medical University of Graz | |||||||||||||
Full Title: Treatment of retinal angiomatous proliferation lesions due to age-related macular degeneration with ranibizumab (Lucentis®) and photodynamic therapy with verteporfin (Visudyne®) | |||||||||||||
Medical condition: Subtype of neovascular age-related macular degeneration, so called retinal angiomatous proliferation or RAP. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005290-30 | Sponsor Protocol Number: TCA-05-01 | Start Date*: 2006-10-18 | |||||||||||
Sponsor Name:Department of Ophthalmology, Semmelweis University | |||||||||||||
Full Title: A Non- randomized, Single-Center, Open Label Case Series Study of Intravitreal Triamcinolone Acetate Injections (IVTA) Used as Adjunctive to Verteporfin Photodynamic Therapy (PDT) in the Treatment ... | |||||||||||||
Medical condition: Age- related macular degeneration with predominantly classic subfoveal choroidal neovascularisation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016926-15 | Sponsor Protocol Number: OFT-09-01 | Start Date*: 2010-03-11 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Intravitreal Bevacizumab associated with epiretinal brachitherapy as a treatment for Coroidal Neovascularization (CNV) secondary to exudative Age Related Macular Degeneration (AMD) | |||||||||||||
Medical condition: exudative Age Related Macular Degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005684-26 | Sponsor Protocol Number: Version_1_10072006 | Start Date*: 2007-09-06 | |||||||||||||||||||||
Sponsor Name:Universitätsklinik für Augenheilkunde und Optometrie, AKH Wien | |||||||||||||||||||||||
Full Title: Identification and Quantification of Cytokines in Anti-VEGF Therapy and Genetic Risk Factors in Exsudative Age-related Macular Degeneration | |||||||||||||||||||||||
Medical condition: Exsudative age-related macular degeneration (AMD), cataract, macular pucker | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-014444-11 | Sponsor Protocol Number: RET04.09 | Start Date*: 2009-08-10 | |||||||||||
Sponsor Name:IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS | |||||||||||||
Full Title: Functional and morphological retinal changes in diabetic macular edema treated with pegaptanib | |||||||||||||
Medical condition: Diabetic Macular Edema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-021968-15 | Sponsor Protocol Number: ID_2909 | Start Date*: 2010-08-06 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA | |||||||||||||
Full Title: NOT RANDOMISED OPEN LABEL STUDY TO COMPARE EFFICACY OF BEVACIZUMAB (AVASTIN, ROCHE) VERSUS RANIBIZUMAB (LUCENTIS, NOVARTIS) ADMINISTERED BY INTRAVITREAL INJECTION IN PATIENTS WITH EXUDATIVE AGE REL... | |||||||||||||
Medical condition: exudative age related macular degeneration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000765-20 | Sponsor Protocol Number: ANTIVEGFVEP | Start Date*: 2015-11-27 | |||||||||||||||||||||
Sponsor Name:Kuopion yliopistollinen sairaala/silmätautien poliklinikka | |||||||||||||||||||||||
Full Title: The Effect of Intravitreal Bevacizumab Injections in Patients with Macular Oedema Caused by AMD, CRVO or DME on the Plasticity of Nerves Studied by Visual Evoked Potentials | |||||||||||||||||||||||
Medical condition: Wet age-related macular degeneration, diabetic macular edema, central retinal vein occlusion | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FI (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005789-30 | Sponsor Protocol Number: IOBA-03-2008 | Start Date*: 2009-04-22 | ||||||||||||||||
Sponsor Name:María Isabel López Gálvez-Instituto Universitario de Oftalmobiología Aplicada-Universidad Valladolid | ||||||||||||||||||
Full Title: Estudio de la eficacia y seguridad de inyecciones intravítreas de bevacizumab en el edema macular secundario a oclusiones venosas retinianas (EBOVER) | ||||||||||||||||||
Medical condition: Edema macular secundario a oclusiones venosas retinianas | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
